- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
4Dmedical Ltd (4DX)
Track today's live 4Dmedical (4DX) share price, performance and key data on this page with our current Sydney:4DX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the 4Dmedical share price on the Sydney exchange. Use the dropdown to switch exchange for the 4DX share price, head to our technical summary section, which provides analysis on 4Dmedical share price buy/sell indicators using real-time data (or discuss the 4Dmedical (4DX) stock price today with other investors in the 4Dmedical ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX:4DX share price (ISIN: AU0000095416) to enhance your trading decisions with our free investment tools and resources.
What Is the 4Dmedical Ltd Share Price Today?
The 4Dmedical share price today is 4.07.
What Is the Stock Symbol for 4Dmedical Ltd
The stock symbol (or 'ticker') for 4Dmedical Ltd is "4DX."
What Stock Exchange Does 4Dmedical Ltd Trade On?
4Dmedical Ltd is listed and trades on the Sydney stock exchange.
Is 4Dmedical Ltd a Good Stock to Buy?
Determining whether 4Dmedical (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ASX:4DX share price (ISIN: AU0000095416) to enhance your trading decisions with our free investment tools and resources.
What Is the 4Dmedical Ltd Share Price Today?
The 4Dmedical share price today is 4.07.
What Is the Stock Symbol for 4Dmedical Ltd
The stock symbol (or 'ticker') for 4Dmedical Ltd is "4DX."
What Stock Exchange Does 4Dmedical Ltd Trade On?
4Dmedical Ltd is listed and trades on the Sydney stock exchange.
Is 4Dmedical Ltd a Good Stock to Buy?
Determining whether 4Dmedical (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
4.07
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.00
4.19
52 wk Range
1.40
7.55
4DX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.004.19
52 wk Range
1.407.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4DX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
4.37
Upside
+7.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
1 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 4.37
(+7.29% Upside)
Earnings
Latest Release
28/08/2026
EPS / Forecast
-0.07 / -0.03
Revenue / Forecast
4.21M / 3.41M
Compare 4DX to Peers and Sector
Metrics to compare | 4DX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4DXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.0x | −3.0x | −0.3x | |
PEG Ratio | 0.03 | 0.00 | 0.00 | |
Price/Book | 14.4x | 1.6x | 2.6x | |
Price / LTM Sales | 346.7x | 3.6x | 3.0x | |
Upside (Analyst Target) | 7.3% | 90.2% | 58.5% | |
Fair Value Upside | Unlock | 7.0% | 7.1% | Unlock |
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in medical research technology and development of a non invasive respiratory imaging solution. It offers CT:VQ, non-contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company has partnership with AstraZeneca to launch and expand a lung health screening program; and a contractual engagement with GlaxoSmithKline to provide its proprietary quantitative lung imaging analytics in support of pulmonary drug development and clinical research. 4DMedical Limited was incorporated in 2012 and is based in Carlton, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the 4Dmedical (Sydney: 4DX) Share Price Today?
The 4Dmedical stock price today is 4.07 AUD.
What Stock Exchange Does 4Dmedical (4DX) Trade On?
4Dmedical is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for 4Dmedical?
The stock symbol (also called a 'ticker') for 4Dmedical is "4DX."
What Is the Current 4Dmedical Market Capitalisation?
As of today, 4Dmedical (Sydney: 4DX) market cap is 2.45B AUD.
What Is 4Dmedical's (4DX) Earnings Per Share (TTM)?
The 4Dmedical EPS is currently -0.38 (Trailing Twelve Months).
When Is the Next 4Dmedical Earnings Date?
4Dmedical's next earnings report will be released on 02/12/2026.
Is 4DX a Buy or Sell From a Technical Analyst Perspective?
Based on today's 4Dmedical moving averages and other technical indicators, the daily buy/sell signal for 4DX stock is Buy.
How Many Times Has 4Dmedical Stock Split?
4Dmedical has split 0 times. (See the 4DX stock split history page for full effective split date and price information.)
How Many Employees Does 4Dmedical Have?
4Dmedical has 181 employees, based on their latest Companies House report.
What is the current trading status of 4Dmedical (Sydney: 4DX)?
As of 06/10/2026, 4Dmedical (4DX) is trading at a share price of 4.07 AUD, with a previous close of 4.07 AUD. The stock has fluctuated within a day range of 4.00 AUD to 4.19 AUD, while its 52-week range spans from 1.40 AUD to 7.55 AUD.
What Is 4Dmedical (4DX) Price Target According to Analysts?
The average 12-month price target for 4Dmedical is 4.37 AUD, with a high estimate of 6 AUD and a low estimate of 3 AUD. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +7.29% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.